Hydroxocobalamin Use in Intensive Care Patients with Vasodilatory Shock - A Scoping Review

2026 Preprint Open access

Read full text
Authors: Adrian Pakavakis, Robert Olver, Neil J. Glassford
DOI: 10.17605/osf.io/cwnq8
Cited by: 0

Abstract

This scoping review will examine the evidence for the use of Hydroxocobalamin, a manufactured from of vitamin B12, in vasodilatory shock in adult patients in the Intensive Care Unit. The review will explore four domains regarding the use of hydroxocobalamin: indication for administration, method of administration, biochemical/physiological outcomes, patient centred outcomes.

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Hemodynamic Monitoring and Therapy Trauma Hemostasis Coagulopathy Resuscitation

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint